Laporan Laba Rugi VLS - TTM - Vita Life Sciences Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Vita Life Sciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	46	46	48	50	54	57	61	64	65	67	68	69	71	73	76	78	79	80	83	86
Change (%)		2.02	3.98	3.83	6.89	6.45	6.14	5.78	2.16	2.12	1.28	1.26	3.52	3.40	3.41	3.30	0.68	0.68	3.83	3.69
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	16	17	18	19	21	22	24	26	27	27	28	28	30	31	32	33	33	32	33	34
Change (%)		5.16	5.80	5.48	8.04	7.44	8.35	7.70	2.18	2.13	2.22	2.17	4.75	4.53	2.77	2.70	-0.77	-0.77	2.62	2.55
% of Revenue	35.92	37.02	37.67	38.27	38.68	39.04	39.85	40.58	40.58	40.59	40.96	41.33	41.82	42.28	42.02	41.77	41.17	40.58	40.11	39.66

Gross Operating Profit	29	29	30	31	33	35	36	38	39	40	40	40	41	42	44	46	46	47	49	52
Change (%)		0.26	2.92	2.84	6.18	5.82	4.72	4.51	2.16	2.11	0.63	0.63	2.66	2.59	3.88	3.74	1.72	1.69	4.66	4.45
% of Revenue	64.08	62.98	62.33	61.73	61.32	60.96	60.15	59.42	59.42	59.41	59.04	58.67	58.18	57.72	57.98	58.23	58.83	59.42	59.89	60.34

SG&A	22	21	22	22	23	24	25	26	27	29	29	29	30	30	32	33	34	35	37	39
Change (%)		-1.11	1.93	1.90	3.00	2.92	5.76	5.44	4.68	4.47	0.91	0.91	1.61	1.59	4.79	4.57	3.22	3.12	4.76	4.55
% of Revenue	47.44	45.99	45.08	44.24	42.63	41.22	41.07	40.94	41.94	42.91	42.75	42.60	41.82	41.08	41.63	42.15	43.21	44.26	44.66	45.02

R&D
Change (%)
% of Revenue

OpEx	38	39	40	42	44	46	49	53	54	56	57	58	60	62	64	66	67	68	70	73
Change (%)		1.57	3.58	3.45	5.27	5.00	7.16	6.68	3.29	3.19	1.41	1.39	3.30	3.19	3.88	3.74	1.14	1.13	3.81	3.67
% of Revenue	84.08	83.72	83.39	83.08	81.82	80.71	81.49	82.18	83.09	83.96	84.07	84.18	84.00	83.83	84.21	84.57	84.96	85.34	85.32	85.30

Operating Income	7	8	8	8	10	11	11	11	11	11	11	11	11	12	12	12	12	12	12	13
Change (%)		4.35	6.08	5.74	14.87	12.95	1.86	1.82	-3.04	-3.14	0.56	0.56	4.73	4.51	0.96	0.95	-1.85	-1.89	3.97	3.82
% of Revenue	15.92	16.28	16.61	16.92	18.18	19.29	18.51	17.82	16.91	16.04	15.93	15.82	16.00	16.17	15.79	15.43	15.04	14.66	14.68	14.70

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0				-0	-0	-0	-0	-0	-0	-0	-0
Change (%)		7.56	-29.30	-41.44	3.77	3.64	-0.00	-0.00	-50.00					100.00	-0.00	-0.00	-11.67	-13.21	-0.00	-0.00
% of Revenue	-0.26	-0.28	-0.19	-0.11	-0.10	-0.10	-0.09	-0.09	-0.04				-0.04	-0.08	-0.08	-0.08	-0.07	-0.06	-0.06	-0.05

Net Income	6	6	6	7	8	8	8	8	8	7	7	7	8	9	9	9	9	9	9	9
Change (%)		9.21	5.11	4.86	11.72	10.49	-0.28	-0.28	-7.04	-7.57	2.37	2.32	11.19	10.06	1.82	1.78	-3.24	-3.53	2.99	2.91
% of Revenue	12.25	13.11	13.25	13.38	13.99	14.52	13.64	12.86	11.70	10.59	10.71	10.82	11.62	12.37	12.18	12.00	11.53	11.05	10.96	10.88

Source: Capital IQ

Vita Life Sciences Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)